阿奇霉素对阿霉素与白蛋白致小鼠肾损害的保护作用*

doi:10.12047/j.cjap.5879.2019.120

中国应用生理学杂志 ›› 2019, Vol. 35 ›› Issue (6): 548-550.doi: 10.12047/j.cjap.5879.2019.120

阿奇霉素对阿霉素与白蛋白致小鼠肾损害的保护作用^*

唐逸豪¹, 殷成哲², 李凯³, 李伟鑫⁴, 范春芳^1△

1. 中国人民武警特色医学中心药剂科, 天津 300162;
2. 武警天津市总队执勤第一支队勤务保障大队卫生队药师, 天津 300202;
3. 江苏总队镇江支队勤务保障大队卫生队军医, 镇江 212000;
4. 武警后勤学院, 天津 300300

收稿日期:2019-05-13 出版日期:2019-11-28 发布日期:2020-04-02
通讯作者: 天津市救援医学临床医学研究中心(15ZXLCSY00040)

Protective effects of azithromycin on adriamycin-induced nephropathy with albumin overload in mice

TANG Yi-hao¹, YIN Cheng-zhe², LI Kai³, LI Wei-xin⁴, FAN Chun-fang^1△

1. Department of Pharmacy, Characteristic Medical Center of Chinese People's Armed Police Force, Tianjin 300162;
2. Pharmacist, Health Team, Service Support Group, No.1 Detachment, Tianjin Armed Police Corps, Tianjin 300202;
3. Military Doctor of Health Team of Zhenjiang Branch Service Support Brigade, Jiangsu Corps, Zhenjiang 212000;
4. Logistics College of Chinese People's Armed Police Force, Tianjin 300300, China

Received:2019-05-13 Online:2019-11-28 Published:2020-04-02

摘要/Abstract

摘要： 目的:研究阿奇霉素对阿霉素与白蛋白致小鼠肾损害的肾脏保护作用。方法:取BALB/c雄性小鼠40只,按照随机数表法平均分为空白对照组(Ctrl组)、肾损害模型组(ADR+BSA组)、阿奇霉素治疗组(Azm组)及醋酸泼尼松阳性对照组(Pdn组);ADR+BSA、AZM及Pdn三组每周5 d尾静脉注射9.8 mg·kg^-1阿霉素,腹腔注射10 mg·kg^-1血清白蛋白,对照组注射生理盐水,持续4周造模;之后,AZM组每天给予62.5 mg·kg^-1阿奇霉素灌胃,Pdn组每天给予12.5 mg·kg^-1醋酸泼尼松灌胃,其余两组给予等量生理盐水,持续6周后,收集并记录24 h尿量,检测尿蛋白量、内生肌酐清除率,取血检测血清生化指标和免疫因子。结果:与Ctrl组相比,ADR+BSA组小鼠24 h尿蛋白定量显著升高(P＜0.05),Ccr显著降低(P＜0.05);经过阿奇霉素治疗后的小鼠,24 h蛋白定量相比于ADR+BSA组显著降低(P＜0.05),Ccr显著升高(P＜0.05)。结论:阿奇霉素对阿霉素与白蛋白致小鼠的肾损害有一定的保护作用。

关键词: 阿奇霉素, 白蛋白过载, 阿霉素, 肾脏保护, 小鼠

Abstract: Objective: To study the protective effects of azithromycin on renal damage induced by doxorubicin and albumin in mice. Methods: Forty male BALB/c mice were randomly divided into blank control group (Ctrl group), renal damage model group (ADR+BSA group), azithromycin treated group (Azm group) and prednisone acetate positive control group (Pdn group) in accordance with random number table method. Mice in ADR+BSA, AZM and Pdn group were injected intravenously with 9.8 mg·kg^-1 doxorubicin five days a week, 10 mg·kg^-1 serum albumin was injected intraperitoneally, and normal saline was administered to the control group for 4 weeks to establish renal damage model. After that, AZM group was given daily. 62.5 mg·kg^-1 azithromycin was intragastrically administered. The Pdn group was given 12.5 mg·kg^-1 prednisone acetate daily, the other two groups were given the same amount of normal saline. After 6 weeks, the urine volume was collected and recorded for 24 hours to detected urine protein amount and endogenous creatinine clearance rate (Ccr). Serum biochemical indicators and serum immune factors were detected. Results: Compared with the Ctrl group, the 24 h urine protein level of the ADR+BSA group was increased significantly (P＜0.05), and the Ccr was decreased significantly (P＜0.05). After the azithromycin treatment, the 24 h urine protein was decreased significantly (P＜0.05), while the Ccr was increased significantly (P＜0.05) compared with ADR+BSA group. Conclusion: Azithromycin has a protective effects on the renal damage induced by doxorubicin and albumin in mice.

Key words: azithromycin, albumin overload, adriamycin, renal protection, mice

中图分类号:

R363

唐逸豪, 殷成哲, 李凯, 李伟鑫, 范春芳. 阿奇霉素对阿霉素与白蛋白致小鼠肾损害的保护作用^*[J]. 中国应用生理学杂志, 2019, 35(6): 548-550.

TANG Yi-hao, YIN Cheng-zhe, LI Kai, LI Wei-xin, FAN Chun-fang. Protective effects of azithromycin on adriamycin-induced nephropathy with albumin overload in mice[J]. CJAP, 2019, 35(6): 548-550.

参考文献

[1] Lafayette RA, Canetta PA, Rovin BH, et al. A randomized, controlled trial of rituximab in iga nephropathy with proteinuria and renal dysfunction[J]. J Am Soc Nephrol, 2017, 28(4): 1306-1313.
[2] Colucci M, Corpetti G, Emma F, et al. Immunology of idiopathic nephrotic syndrome[J]. Pediatric Nephrology, 2018, 33(4): 573-584.
[3] Külcü NU, Camcloglu Y, Aktas E, et al. The effect of systemic antibiotics, leukotriene receptor antagonist montelukast and azithromycin on Th1/Th2 cytokine levels in cystic fibrosis patients[J]. J Cyst Fibros, 2010, 9(S1): S49.53-60
[4] Cao Q, Wang Y, Zheng D, et al. IL-10/TGF-beta-modified macrophages induce regulatory T cells and protect against adriamycin nephrosis[J]. J Am Soc Nephrol, 2010, 21(6): 933-942.
[5] Yagmurca M, Erdogan H, Iraz M, et al. Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats[J]. Clin Chim Acta, 2004, 348(1-2): 27-34.
[6] 贺升升, 李爱平, 张王宁, 等. 阿霉素肾病模型及其病理机制研究进展[J]. 中草药, 2018, 49(22): 5426-5434.
[7] 李园园. IL-17及相关趋化因子在阿霉素肾病小鼠和足细胞中的作用机制研究 [D]. 山东大学, 2016.
[8] 支勇, 曹式丽.阿霉素肾病动物模型的国外研究进展[J]. 中国中西医结合肾病杂志, 2008, 9(10): 933-935.
[9] Vaziri ND. HDL abnormalities in nephrotic syndrome and chronic kidney disease[J]. Nat Rev Nephrol, 2015, 12(1): 37-47.
[10]Lee VW, Harris DC. Adriamycin nephropathy: a model of focal segmental glomerulosclerosis[J]. Nephrology, 2011, 16(1): 30-38.
[11]Okuda S, Oh Y, Tsuruda H, et al. Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease[J]. Kidney Int, 1986, 29(2): 502-510.
[12]Fogo AB. Animal models of FSGS: lessons for pathogenesis and treatment[J]. Semin Nephrol, 2003, 23(2): 161-171.
[13]Tagawa A, Yasuda M, Kume S, et al. Impaired podocyte autophagy exacerbates proteinuria in diabetic nephropathy[J]. Diabetes, 2016, 65(3): 755-767.
[14]Kim JH, Xie J, Hwang KH, et al. Klotho may ameliorate proteinuria by targeting TRPC6 channels in podocytes[J]. J Am Soc Nephrol, 2017, 28(1): 140-151.
[15]杨维娜, 于琳华, 钱亦华, 等. 阿霉素肾病大鼠模型动态变化及其足细胞数量和nephrin的表达变化 [J]. 中山大学学报(医学科学版), 2009, 30(5): 512-516.
[16]Bobulescu IA. Renal lipid metabolism and lipotoxicity[J]. Curr Opin Nephrol Hy, 2010, 19(4): 393-402.
[17]李瑶, 魏心怡, 闫俊丽, 等. 白蛋白过载加重阿霉素肾病小鼠肾损害及辛伐他汀的肾脏保护作用[J]. 中国病理生理杂志, 2017, 33(2): 308-314.

阿奇霉素对阿霉素与白蛋白致小鼠肾损害的保护作用^*

Protective effects of azithromycin on adriamycin-induced nephropathy with albumin overload in mice

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	白林林, 王志华, 宁学聪, 巩翠珂, 李爱敏, 段玉玲, 焦雨佼. IL-17A对慢性阻塞性肺疾病的干预作用及其机制^*[J]. 中国应用生理学杂志, 2021, 37(6): 584-588.
[2]	薛峰, 王辉, 许思多, 刘首挺, 龚永生, 范小芳. 左旋卡尼汀对脂多糖诱导小鼠肺微血管内皮细胞自噬和凋亡的影响^*[J]. 中国应用生理学杂志, 2021, 37(6): 589-593.
[3]	李莉, 黄涵柽. 莱菔子乙醇提取物对ApoE^-/-小鼠血脂血糖及肝脂肪变性的影响^*[J]. 中国应用生理学杂志, 2021, 37(6): 622-627.
[4]	胡佳楠, 姜辉, 李美琦, 朱俐, 骆倩倩. 模拟高原低氧环境对小鼠脾脏铁代谢的影响^*[J]. 中国应用生理学杂志, 2021, 37(6): 628-631.
[5]	李萍, 梁琳琅, 王宇, 侯达, 杨昕, 杨博. 二甲双胍和西格列汀对胰岛素抵抗糖尿病前期KKAy小鼠胰岛β细胞功能的影响^*[J]. 中国应用生理学杂志, 2021, 37(6): 644-649.
[6]	袁前发, 何珏, 徐志忠, 林多朵, 朱敬敬, 温春燕, 段海珍, 王文强. 重复经颅磁刺激联合低剂量氟西汀对CUMS抑郁小鼠的影响^*[J]. 中国应用生理学杂志, 2021, 37(6): 650-653.
[7]	谢文杰, 周刚, 李鹏飞, 杨帆, 安静芳, 李航. 游泳训练对小鼠心肌PKCδ/P66shc蛋白表达的影响^*[J]. 中国应用生理学杂志, 2021, 37(6): 688-693.
[8]	王小琴, 石卉, 方小霞, 彭聿平. α1-肾上腺素受体对胶原诱导性关节炎小鼠Treg细胞功能的影响^*[J]. 中国应用生理学杂志, 2021, 37(5): 449-453.
[9]	陈旭娥, 马婷, 盛良, 王文雯, 李季. IL-21单克隆抗体对MRL/lpr狼疮小鼠的治疗作用^*[J]. 中国应用生理学杂志, 2021, 37(5): 467-470.
[10]	贺英昊, 方情, 杨玲玲, 陈思敏, 骆燕萍, 钱虹, 齐敏友. 酮康唑对小鼠肝脏和睾丸生理功能的影响^*[J]. 中国应用生理学杂志, 2021, 37(5): 475-479.
[11]	臧茂林, 余梦迪, 陈重华, 黄梦琪, 罗鹏, 樊红琨, 杨春. 腹主动脉缩窄小鼠心脏结构和功能的动态变化^*[J]. 中国应用生理学杂志, 2021, 37(5): 479-482.
[12]	赵士博, 黄锁义, 潘智, 彭晓敏, 彭晓靖, 伍世娟, 韦德智, 陈新鹏. 薏苡叶和淫羊藿配伍对小鼠抗疲劳及耐缺氧的作用^*[J]. 中国应用生理学杂志, 2021, 37(5): 510-513.
[13]	朱明了, 郑珍, 楼恩哲, 赵凯婷, 何施燕, 陈佳玉. 大蒜阿霍烯抗胃癌的作用及分子机制^*[J]. 中国应用生理学杂志, 2021, 37(5): 514-519.
[14]	陈奕帆, 张李君, 刘清华, 李学文. 西格列汀对糖尿病小鼠心肌重构和自噬的影响及其机制[J]. 中国应用生理学杂志, 2021, 37(5): 534-537.
[15]	欧阳昕, 李清, 肖爱娇, 陈明人. 艾灸对缺氧缺血性脑损伤新生小鼠的治疗作用^*[J]. 中国应用生理学杂志, 2021, 37(5): 543-547.